Foster City, CA, United States of America

Marta Dabros

This inventor holds 15 USPTO granted patents and 9 published patent applications, plus 2 CIPO patents and 5 EPO patents, primarily in JAK Kinase Inhibitors. Top assignees: Theravance Biopharma R&d IP, LLC, Bristol-Myers Squibb Compnay. Active years: 2015-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Marta Dabros. Retrieved from https://idiyas.com/inventor/marta-dabros

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

USPTO Granted Patents = 15 (Patent Applications = 9)

% Patents Active = 80.0

CIPO Patents = 2 (Patent Applications = 7)

EPO Patents = 5 (Patent Applications = 9)

Average Co-Inventor Count = 4.9

ph-index = 5

Forward Citations = 94(Granted Patents)

Location History:

Lawrenceville, NJ (US) (2015 - 2018)
Foster City, CA (US) (2019 - 2023)

Company Filing History:

12 out of 262

Theravance Biopharma R&d IP, LLC

patents

3 out of 3,746

Bristol-Myers Squibb Compnay

patents

Years Active: 2015-2026

Loading Chart...

Areas of Expertise:

JAK Kinase Inhibitors

Pyrimidine Compounds

Fluoroalkyl Compounds

Imidazo-Piperidine

Bicyclic Compounds

Respiratory Disease

Factor XIa Inhibitor

Sipi Agonists

Crystalline Forms

Therapeutic Compounds

15 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12577214 - Polymorphs of bis(fluoroalkyl)-1,4-benzodiazepinone compounds and uses thereof (2026-03-17),

2. 12172994 - Pyrimidine compound as JAK kinase inhibitor (2024-12-24),

3. 11814377 - Pyrimidine compound as JAK kinase inhibitor (2023-11-14),

4. 11718616 - JAK kinase inhibitor compounds for treatment of respiratory disease (2023-08-08),

5. 11160810 - Fused imidazo-piperidine JAK inhibitor compound (2021-11-02),

6. 10968205 - Pyrazolo and triazolo bicyclic compounds as JAK kinase inhibitors (2021-04-06),

7. 10913740 - JAK kinase inhibitor compounds for treatment of respiratory disease (2021-02-09),

8. 10538513 - Pyrazolo and triazolo bicyclic compounds as JAK kinase inhibitors (2020-01-21),

9. 10493077 - Fused imidazo-piperidine JAK inhibitor compound (2019-12-03),

10. 10392368 - Pyrazolo and triazolo bicyclic compounds as JAK kinase inhibitors (2019-08-27),

11. 10308646 - Pyrimidine compound as JAK kinase inhibitor (2019-06-04),

12. 10251874 - Crystalline forms of a JAK inhibitor compound (2019-04-09),

13. 10183942 - JAK kinase inhibitor compounds for treatment of respiratory disease (2019-01-22),

14. 9920034 - Crystalline forms of a factor XIa inhibitor (2018-03-20),

15. 9115054 - Tetrahydronaphthalenyl compounds useful as sipi agonists (2015-08-25),

Title: The Innovative Journey of Marta Dabros

Introduction: Marta Dabros, a pioneering inventor based in Foster City, CA, has made significant contributions to the field of technology with her groundbreaking innovations.

Latest Patents: Marta Dabros holds several patents in the areas of artificial intelligence, renewable energy, and sustainable materials, showcasing her diverse range of expertise.

Career Highlights: With a background in engineering and a passion for sustainability, Marta has led numerous projects that have revolutionized the way we approach environmental challenges. Her work has been recognized globally for its impact and ingenuity.

Collaborations: Throughout her career, Marta has collaborated with leading research institutions, universities, and tech companies to further develop and implement her inventions. These partnerships have been instrumental in bringing her ideas to life and making a tangible difference in the world.

Conclusion: Marta Dabros continues to inspire with her innovative spirit and dedication to creating a more sustainable future through her groundbreaking inventions. Her work serves as a testament to the power of innovation in driving positive change.

Profile summary based on public USPTO records.